ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)
$17.08 -0.04 (-0.2336%)
Analysed ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) News Sources
Global Growth Companies With High Insider Ownership In April 2026
22-04-2026
yahoo.com
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
12-05-2026
yahoo.com
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
13-05-2026
yahoo.com
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
22-05-2026
yahoo.com
Global Growth Companies Insiders Favor With Up To 40% Earnings Growth
25-05-2026
yahoo.com
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
31-05-2026
yahoo.com
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
31-05-2026
yahoo.com
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
31-05-2026
yahoo.com
Ascentage Pharma (AAPG) Reports Phase 1b Olverembatinib Data
05-06-2026
yahoo.com
A Look At Ascentage Pharma Group International’s Valuation After Recent Share Price Weakness
08-06-2026
yahoo.com
What is the current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is $17.08.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is $-0.04.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is -0.2336%.
What is the most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is .
SEC-8K** Filing Available For ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.